Spanish oil company Repsol plans to invest 4 billion euros ($4.2 billion) in data centres, Expansion newspaper reported on Monday, citing unidentified sources close to the process. Spain's Repsol ...

Greetings, CBR readers! We hope you had a fantastic holiday break and a stellar start to 2025. The world collectively burned through a lot of vacation days these past few weeks. The CBR Community ...

In February, motorcycle enthusiasts, particularly fans of the iconic Honda CBR1000RR Fireblade, will have a unique opportunity to acquire a 20-year-old model in like-new condition. The bike will go ...

Repsol has fired up its first exploration drilling campaign in Libya for more than a decade. The Spanish player has resumed exploration activity in the Murzuq basin, its first effort with the ...

And, at the peak of Honda Sportbike performance, is the Fireblade, also known as the CBR1000RR-R Fireblade SP or the Triple-R. It has Tony-the-Tiger levels of R's. Nestled in there, just below the ...

It's never too early to plan your penny-saving with a Steam Sale schedule. In times past, predicting Steam sales was more soothsaying than science, but we're in a beautiful new world of ...

Libya’s state National Oil Corporation (NOC) reported yesterday (31 December 2024) that Spanish oil company Repsol has resumed exploration activity in the Murzuq Basin after a hiatus of more than a ...

Tripoli, December 31, 2024 (LANA) - The National Oil Corporation announced that the Spanish exploration company "Repsol" has resumed its exploration activity in the Murzuq Basin, after a hiatus that ...

What’s going on here? Colombia's energy heavyweight, Ecopetrol, has struck a deal with Repsol to snag a 45% stake in the CPO-09 oil block, boosting its footprint in the nation's oil sector.

CAIRO, Dec 31 (Reuters) - Spain’s Repsol (REP.MC), opens new tab has resumed oil exploration in Libya after 10 years, the state oil firm NOC said in a statement on Tuesday. NOC said Repsol had ...

Mesoblast (ASX:MSB) was the top performer for the year up 835% (as of December 30). On December 18 Mesoblast announced that the US Food and Drug Administration (FDA) had finally approved its therapy ...